TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$244 Million

Adaptive Biotechnologies Corp.

Follow-on Offering

Passive Bookrunner, January 2020

Adaptive Biotechnologies Corp.
Adaptive is advancing the field of immune driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.